Table: Xebio Holdings - 9-MTH group results
Feb 13 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 188.80 188.26 253.53
(+0.3 pct) (+3.4 pct) (+1.2 pct)
Operating 2.49 6.08 4.02
(-58.9 pct) (+30.4 pct) (-42.7 pct)
Recurring 4.08 6.94 5.08
(-41.2 pct) (+29.3 pct) (-33.3 pct)
Net 866 mln 3.93 236 mln
(-77.9 pct) (+20.9 pct) (-75.7 pct)
EPS 20.93 yen 90.60 yen 5.49 yen
EPS Diluted 20.78 yen 90.01 yen
Ann Div 32.50 yen 35.00 yen
-Q2 div 17.50 yen 15.00 yen
-Q4 div 17.50 yen 17.50 yen
NOTE - Xebio Holdings Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T